W.R.M. Aengevaeren

LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis.

Abraham A. Kroon, W.R.M. Aengevaeren, Tjeerd van der Werf et al. · PubMed · 1996 · 273 citations

Medicine, Pharmacology, Pharmacotherapy +16

Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial

Alexander Hirsch, Robin Nijveldt, Pieter A. van der Vleuten et al. · European Heart Journal · 2010 · 239 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Aspirin Plus Coumarin Versus Aspirin Alone in the Prevention of Reocclusion After Fibrinolysis for Acute Myocardial Infarction

Marc A. Brouwer, Paul J.P.C. van den Bergh, W.R.M. Aengevaeren et al. · Circulation · 2002 · 147 citations

Medicine, Cardiology, Pharmacotherapy +17

Sedentary behaviour in cardiovascular disease patients: Risk group identification and the impact of cardiac rehabilitation

Esmée A. Bakker, Bram M. A. van Bakel, W.R.M. Aengevaeren et al. · International Journal of Cardiology · 2020 · 100 citations · Full text

Medicine, Cardiology, Rehabilitation Medicine +17

Mean transit time for the assessment of myocardial perfusion by videodensitometry.

N. H. J. Pijls, G.J.H. Uijen, Albert Hoevelaken et al. · Circulation · 1990 · 98 citations

Medicine, Cardiology, Physiology +17